Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee (Q87570199)
Jump to navigation
Jump to search
scientific article published on 29 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee |
scientific article published on 29 March 2014 |
Statements
Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee (English)
Paul J Tiseo
Alan J Kivitz
John E Ervin
Haobo Ren